Neurocrine Biosciences Inc at Wells Fargo Healthcare Conference Transcript
Great. Thank you very much for joining us today. One more session to go after that. So we are close to being done. Thank you very much. My name is Mohit Bansal. I'm one of the biopharma analysts here at Wells Fargo, and I'm very happy to have Neurocrine management team with us. We have Kyle Gano, the Chief Business Development and Strategy Officer at Neurocrine. And we also have Todd Tushla, the Vice President at Investor Relations. Thank you, Kyle and Todd, for joining us today.
Thank you.
So maybe if you can -- before we get into Q&A, Kyle, if you can give a brief overview of what you are doing right now? And in terms of what is -- like when you talk to investors, what is on top of everyone's mind, so we can just frame the question today?
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |